Ohio Public Employees Retirement System (OPERS)’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio JNCE Stock Details JNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,882	Closed	-$5K	–	2048
2022 Q4	$5K	Sell	4,882 -1,108	-18%	-$1.58K	﹤0.01%	1960
2022 Q3	$14K	Sell	5,990 -13,000	-68%	-$46K	﹤0.01%	2015
2022 Q2	$58K	Buy	18,990 +4,687	+33%	+$22.8K	﹤0.01%	1805
2022 Q1	$97K	Hold	14,303	–	–	﹤0.01%	1727
2021 Q4	$119K	Buy	+14,303	New	+$118K	﹤0.01%	1661
2021 Q1	–	Sell	-7,088	Closed	-$50K	–	2021
2020 Q4	$50K	Hold	7,088	–	–	﹤0.01%	1821
2020 Q3	$58K	Hold	7,088	–	–	﹤0.01%	1660
2020 Q2	$49K	Hold	7,088	–	–	﹤0.01%	1712
2020 Q1	$34K	Buy	7,088 +2,888	+69%	+$16.6K	﹤0.01%	1707
2019 Q4	$37K	Hold	4,200	–	–	﹤0.01%	1820
2019 Q3	$14K	Buy	+4,200	New	+$16.8K	﹤0.01%	1943

Other funds holding JNCE

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

ACM

Ardent Capital Management Cincinnati, Ohio $241M AUM 23.63% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s JNCE Position: Q1 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q1 2023, closing a stake of 4,882 shares — an estimated $5K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in JNCE in Q3 2019 and held it in 11 quarters. The position peaked at $119K in Q4 2021. 84 funds tracked by Wall St. Rank hold JNCE as of Q1 2023.

Ohio Public Employees Retirement System (OPERS) reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 4,882 Jounce Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $5K.
Ohio Public Employees Retirement System (OPERS) first reported a position in Jounce Therapeutics, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
Ohio Public Employees Retirement System (OPERS)'s Jounce Therapeutics, Inc. Common Stock position peaked at $119K in Q4 2021.
84 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2023, filed 15 May 2023.